ON AIR STAR
00:00:00 | 3:02:50

SUPPORT KCRW!

close

FROM THIS EPISODE

Three years of controversy over the "morning-after" pill have damaged the credibility of the Food and Drug Administration. Are crucial decisions based on science or politics and religion? Have wealthy drug companies and other special interests compromised the protection of public health and welfare?  Plus, a "credible force" for peacekeeping in southern Lebanon, and the State Department investigates Israel's use of  American-made cluster bombs in Lebanon in violation of a secret agreement with the US.


Reporter's Notebook State Department Investigates Israel's Use of US-Made Cluster Bombs 10 MIN


Israel says all the weapons it fired in southern Lebanon were legal and used according to international standards, but the UN reports that cluster bombs are littering hundreds of homes and gardens even though they're prohibited against civilian targets. The State Department confirms it's investigating the use of the bombs, some of which might have been sold to Israel by the US. A shipment of cluster-type artillery rockets is being held up. Michael O'Hanlon is a military analyst at the Brookings Institution.

Guests:
Michael O'Hanlon, Brookings Institution (@MichaelEOHanlon)

Making News Europe to Provide More than Half of UN Lebanon Force 6 MIN


UN Secretary General Kofi Annan says a "credible force" can now be sent to southern Lebanon with Europe agreeing to provide almost half the 15,000 soldiers. Marc Champion is reporting from Brussels for the Wall Street Journal.

Guests:
Marc Champion, Wall Street Journal

Main Topic Does Approval of Morning-After Pill Mean Change at FDA? 38 MIN


The mission of the Food and Drug Administration is protection of public health and welfare. To accomplish that, the agency regulates no less than one-fourth of all consumer products sold in the United States. Despite the agency's approval yesterday to sell the "morning-after" pill over the counter, controversy over the FDA will go on for a long time. Religious conservatives claim the pill invites promiscuity and sexually transmitted disease. Women's rights advocates don't like the age limit of 18. We hear those arguments and look at the broader debate about FDA's ability to protect public health and welfare. Are its decisions based on science or religion and ideology? Is it a captive of the wealthy and powerful interests it's supposed to monitor and control?

Guests:
Susan Wood, Former Assistant Commissioner for Women's Health at the FDA
Wendy Wright, Senior Policy Director for Concerned Women for America
Sidney Wolfe, Director of Public Citizen's Health Research Group
John "Jack" Calfee, Resident Scholar, American Enterprise Institute

Events

View All Events

iTUNES SPOTIFY
AMAZON RDIO
FACEBOOK EMAIL
TWITTER COPY LINK